ADULT syndrome

Lore & Background

ADULT syndrome is characterized by a range of signs and symptoms including ectrodactyly, syndactyly, excessive freckling, lacrimal duct anomalies, dysplastic nails, hypodontia, hypoplastic breasts and nipples, hypotrichosis, hypohidrosis, broad nasal bridge, midfacial hypoplasia, exfoliative dermatitis, and xerosis. The absence of facial clefting and ankyloblepharon distinguishes it from ectrodactyly–ectodermal dysplasia–cleft syndrome (EEC).

Reader's Guide

ADULT syndrome holds significance as a distinct entity within the spectrum of TP63-related disorders, clarifying diagnostic boundaries that were previously blurred with EEC syndrome. Its classification in 1993 by Propping and Zerres helped refine understanding of ectodermal dysplasias. The syndrome's features, such as the lack of facial clefting, provide critical differential diagnostic clues. The identification of specific TP63 mutations, particularly R298Q and R243W, aids in genetic counseling and understanding of p63 protein function in limb and ectodermal development. The syndrome's rarity and autosomal dominant inheritance pattern underscore the importance of accurate diagnosis for affected families. Its study contributes to broader knowledge of how p63 mutations lead to varied clinical presentations, from ADULT syndrome to EEC and Hay-Wells syndromes.

Did You Know?

• ADULT syndrome was previously thought to be a form of EEC syndrome but was classified as a different disease in 1993.
• The most common TP63 mutations in ADULT syndrome are R298Q and R243W.
• ADULT syndrome lacks facial clefting and ankyloblepharon, which are present in EEC syndrome.
• The age of onset is generally prenatal or before a newborn reaches 4 weeks old.

Classification & Historical Context

ADULT syndrome, formally known as acro–dermato–ungual–lacrimal–tooth syndrome, is a rare inherited condition that belongs to the broader family of ectodermal dysplasias. These disorders collectively impact structures derived from the ectoderm, including hair, teeth, nails, sweat glands, and the extremities. ADULT syndrome follows an autosomal dominant inheritance pattern, meaning a single altered copy of the responsible gene is sufficient to produce the condition. For years, clinicians assumed this presentation was simply a variant of ectrodactyly–ectodermal dysplasia–cleft syndrome, commonly abbreviated as EEC. It was not until 1993 that researchers Propping and Zerres formally separated ADULT syndrome from EEC, recognizing it as a distinct clinical entity. This reclassification was significant because it acknowledged that the constellation of features seen in ADULT patients—particularly the absence of certain hallmark signs—warranted its own diagnostic category rather than being lumped under a broader syndrome. The recognition of ADULT as a standalone condition has since allowed for more precise genetic counseling and targeted research into its underlying molecular mechanisms.

Clinical Presentation & Onset

The clinical picture of ADULT syndrome typically manifests very early in life, with onset occurring either during the prenatal period or within the first four weeks after birth. The syndrome presents with a wide array of physical findings affecting multiple ectodermal structures. Limb anomalies such as ectrodactyly and syndactyly are prominent features. The skin may show excessive freckling, exfoliative dermatitis, xerosis, thin skin, and even skin ulcers. Nail abnormalities are common, ranging from dysplastic fingernails and toenails to nail pits. Hair is often fine or thinned, a condition termed hypotrichosis, and patients may experience reduced sweating known as hypohidrosis. Dental involvement includes hypodontia, while lacrimal duct anomalies affect normal tear drainage. Facial features can include a broad nasal bridge and midfacial hypoplasia. Additional findings may encompass hypoplastic breasts and nipples, melanocytic nevi, and other dermatological irregularities. The breadth of affected tissues underscores the systemic nature of this ectodermal disorder.

Genetic Basis & the TP63 Gene

At the molecular level, ADULT syndrome is caused by autosomal dominant mutations in the TP63 gene, which encodes the p63 protein. This protein plays a critical role during embryonic development, particularly in the formation of limbs and other ectodermal tissues. When TP63 is disrupted, the developmental programs that shape these structures go awry, producing the characteristic deformities seen in affected individuals. To date, seven distinct mutations in TP63 have been identified in association with ADULT syndrome. The two most frequently encountered are R298Q and R243W. In R298Q, the amino acid arginine at position 298 is replaced by glutamine; in R243W, arginine at position 243 is substituted with tryptophan. It is worth noting that TP63 mutations are not exclusive to ADULT syndrome. The same gene is implicated in other conditions, including ectrodactyly–ectodermal dysplasia–cleft syndrome and Hay-Wells syndrome, highlighting the broad developmental importance of the p63 protein across multiple tissue lineages.

Distinguishing ADULT from EEC Syndrome

One of the most clinically important aspects of ADULT syndrome is how it is differentiated from the closely related ectrodactyly–ectodermal dysplasia–cleft syndrome. Historically, the two conditions were conflated, with ADULT presentations being subsumed under the EEC umbrella. The key distinguishing features are the absence of facial clefting and the absence of ankyloblepharon in ADULT patients. Both of these features are hallmarks of EEC but are notably absent in ADULT syndrome. This critical distinction was formalized in 1993 when Propping and Zerres proposed that the conditions represented separate entities rather than a single spectrum. The practical implication of this separation is substantial: accurate diagnosis affects genetic counseling, prognosis, and the expectation of which complications a patient or family member might face. Recognizing that ADULT syndrome lacks clefting and ankyloblepharon helps clinicians avoid misdiagnosis and ensures that affected families receive appropriate information about the specific condition rather than a broader, less precise classification.

Gallery